Beta
329711

Acute hypervolemic hemodilution combined with controlled hypotension to minimize blood loss during operations of spine fusion: remifentanil versus magnesium sulfate

Article

Last updated: 05 Jan 2025

Subjects

-

Tags

-

Abstract

Background
Blood loss is one of the major problems during operations of spine fusion. Several blood-conservative measures were applied to reduce the incidence of blood loss—among them, acute hypervolemic hemodilution (AHH) and controlled hypotension (CH). This study was designed to detect the effect of combination of AHH with CH induced by remifentanil versus magnesium sulfate on the volume of blood loss, allogeneic blood transfusion, hemodynamics, coagulation, and electrolytes during operations for spine fusion which are risky operations with high incidence of blood loss and blood transfusion. Sixty patients scheduled for posterior fusion of the spine were randomly allocated into three groups of 20 patients each (group I (AHH), group II (AHH combined with remifentanil-based CH), and group III (AHH combined with magnesium sulfate-based CH)). Estimated blood loss and total volume of packed red blood cells (PRBCS) transfused were recorded. Arterial blood pressure (ABP) and heart rate (HR) measures were recorded. Blood samples were obtained for the detection of hemoglobin (Hb) and hematocrit (HCT).
Results
Estimated blood loss, percentage blood loss, and intraoperative RBC transfusion units were significantly high in group I in relation to group II and group III (Table 2). Cardiac output was significantly higher in group I in relation to group II and group III at 10, 15, 30, 45, and 60 min after start of AHH. MBP and HR results were significantly high in group I in comparison with group II and group III at 30, 45, 60, and 90 min and 2 and 3 h after start of study drugs. CVP results were significantly high in group I in relation to group II and group III at 15, 30, 45, 60, and 90 min after start of AHH. PTT was significantly increased in the three study groups in comparison with baseline inside each group after AHH.
Conclusion
Combination of AHH with CH induced by remifentanil or magnesium sulfate was associated with reduction in estimated blood loss, and total volume of PRBCS transfused. There was no significant difference between hemodynamic parameters with the use of remifentanil or magnesium sulfate except that SBP, DBP, and MBP results were significantly high with magnesium sulfate at 15 min after drug infusion. There was significant increase in PT and PTT after AHH that was not reflected by significant blood oozing from the operative field, or by difficulty in hemostasis.

DOI

10.1186/s42077-021-00165-3

Keywords

Acute hypervolemic hemodilution, Controlled hypotension, Remifentanil, magnesium sulfate, Spine fusion

Authors

First Name

Khaled Mohammed

Last Name

Elnaghy

MiddleName

-

Affiliation

-

Email

khaled_elnaghy@hotmail.com

City

-

Orcid

0000-0002-0073-6160

First Name

Ibrahimabd-Elsalam

Last Name

Nasr

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Eman Mohamed

Last Name

Kamal

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

Volume

13

Article Issue

1

Related Issue

44739

Issue Date

2021-01-01

Receive Date

2021-06-11

Publish Date

2021-08-28

Print ISSN

1687-7934

Online ISSN

2090-925X

Link

https://asja.journals.ekb.eg/article_329711.html

Detail API

https://asja.journals.ekb.eg/service?article_code=329711

Order

329,711

Publication Type

Journal

Publication Title

Ain-Shams Journal of Anesthesiology

Publication Link

https://asja.journals.ekb.eg/

MainTitle

Acute hypervolemic hemodilution combined with controlled hypotension to minimize blood loss during operations of spine fusion: remifentanil versus magnesium sulfate

Details

Type

Article

Created At

20 Dec 2024